UBS Group AG - HCW BIOLOGICS INC ownership

HCW BIOLOGICS INC's ticker is and the CUSIP is 40423R105. A total of 14 filers reported holding HCW BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HCW BIOLOGICS INC
ValueSharesWeighting
Q3 2023$403
+1731.8%
212
+1225.0%
0.00%
Q1 2023$22
-97.0%
16
-95.8%
0.00%
Q4 2022$732
-85.4%
381
-81.5%
0.00%
Q2 2022$5,0000.0%2,056
+20.6%
0.00%
Q1 2022$5,000
-95.8%
1,705
-95.4%
0.00%
Q3 2021$119,00037,3840.00%
Other shareholders
HCW BIOLOGICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 82,600$157,7660.00%
HighTower Advisors, LLC 354,869$675,0000.00%
Cresset Asset Management, LLC 131,990$250,7810.00%
Focused Wealth Management, Inc 1,000$1,9000.00%
UBS Group AG 212$4030.00%
TWO SIGMA INVESTMENTS, LP 22,840$43,3960.00%
WELLS FARGO & COMPANY/MN 131$2490.00%
NORTHERN TRUST CORP 10,205$19,3900.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 132,503$253,1710.00%
View complete list of HCW BIOLOGICS INC shareholders